Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

DHT may increase the risk of heart disease and death in elderly men.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.